본문 바로가기
KERD
논문KCI 등재

Impact of Prostate Volume on the Efficacy of High-Power Potassium-Titanyl-Phosphate Photoselective Vaporization of the Prostate: A Retrospective, Short-Term Follow-Up Study on Evaluating Feasibility and Safety

1

조회

0

다운로드

2

인용

0

참고문헌

키워드

주제분류의학일반

초록

Purpose: We determined the impact of prostate volume on the efficacy of the high-power (80 W) potassium-titanyl-phosphate (KTP) photoselective laser vaporization of the prostate in men with lower urinary tract symptoms (LUTS). Materials and Methods: Patients were stratified into 3 groups according to prostate volume: ‘< 40 g’ (n = 49) and ‘40-59 g’ (n = 49) and ‘≥ 60 g’ (n = 22). Median follow-up was 9 months (range 6 to 21). Results: No differences in age and follow-up duration were observed in the three groups. At baseline, no significant differences were noted in the three groups in terms of the International Prostate Symptom Score (IPSS) (21.4, 19.4 and 19.1; p = 0.412) as well as the maximum flow rate (Qmax) (10.2, 9.2, and 8.6 mL/s; p = 0.291) and post-void residual (PVR) (66.2, 80.4, and 71.5 mL; p = 0.856). The mean operative times were 30.9, 46.9, and 58.6 minutes (p < 0.001) and total median energy deliveries for each group were 62.3, 97.6, and 135.9 kJ, respectively (p < 0.001). No severe intraoperative complication was observed. At the last follow-up, these parameters improved significantly regardless of prostate volume, and the IPSS (11.1, 9.4, and 12.3; p = 0.286) as well as Qmax (15.9, 15.9, and 14.2 mL/s; p = 0.690) and PVR (33.7, 28.4, and 14.2 mL; p = 0.395) were not significantly different among the groups. Conclusion: Although a larger prostate requires more time and energy delivery, photoselective laser vaporization of the prostate is safe and efficacious for patients with LUTS regardless of prostate volume.

Abstract

Purpose: We determined the impact of prostate volume on the efficacy of the high-power (80 W) potassium-titanyl-phosphate (KTP) photoselective laser vaporization of the prostate in men with lower urinary tract symptoms (LUTS). Materials and Methods: Patients were stratified into 3 groups according to prostate volume: ‘< 40 g’ (n = 49) and ‘40-59 g’ (n = 49) and ‘≥ 60 g’ (n = 22). Median follow-up was 9 months (range 6 to 21). Results: No differences in age and follow-up duration were observed in the three groups. At baseline, no significant differences were noted in the three groups in terms of the International Prostate Symptom Score (IPSS) (21.4, 19.4 and 19.1; p = 0.412) as well as the maximum flow rate (Qmax) (10.2, 9.2, and 8.6 mL/s; p = 0.291) and post-void residual (PVR) (66.2, 80.4, and 71.5 mL; p = 0.856). The mean operative times were 30.9, 46.9, and 58.6 minutes (p < 0.001) and total median energy deliveries for each group were 62.3, 97.6, and 135.9 kJ, respectively (p < 0.001). No severe intraoperative complication was observed. At the last follow-up, these parameters improved significantly regardless of prostate volume, and the IPSS (11.1, 9.4, and 12.3; p = 0.286) as well as Qmax (15.9, 15.9, and 14.2 mL/s; p = 0.690) and PVR (33.7, 28.4, and 14.2 mL; p = 0.395) were not significantly different among the groups. Conclusion: Although a larger prostate requires more time and energy delivery, photoselective laser vaporization of the prostate is safe and efficacious for patients with LUTS regardless of prostate volume.

참고문헌 (29)

  1. Hai MA, "Photoselective vaporization of the prostate:initial experience with a new 80 W KTP laser for the treatment of benign prostatic hyperplasia", J Endourol, 17, pp.93~96 (2003)
  2. Te AE, "Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia: 12-month results from the first United States multicenter prospective trial", J Urol, 72, pp.1404~1408 (2004)
  3. Sandhu JS, "High-power potassium-titanyl-phosphate photoselective laser vaporization of prostate for treatment of benign prostatic hyperplasia in men with large prostates", Urology, 64, pp.1155~1159 (2004)
  4. Sulser T, "Photoselective KTP laser vaporization of the prostate: first experiences with 65 procedures", J Endourol, 18, pp.976~981 (2004)
  5. Sandhu JS, "Photoselective laser vaporization prostatectomy in men receiving anticoagulants", J Endourol, 19, pp.1196~1198 (2005)
  6. Reich O, "High power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate in 66 high risk patients", J Urol, 173, pp.158~160 (2005)
  7. Kumar SM, "Photoselective vaporization of the prostate: a volume reduction analysis in patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia and carcinoma of the prostate", J Urol, 173, pp.511~513 (2005)
  8. Malek RS, "Photoselective potassiumtitanyl-phosphate laser vaporization of the benign obstructive prostate: observations on long-term outcomes", J Urol, 174, pp.1344~1348 (2005)
  9. Bachmann A, "Photoselective vaporization of the prostate: the basel experience after 108 procedures", Eur Urol, 47, pp.798~804 (2005)
  10. Volkan T, "Short term outcomes of high power (80 W) potassium-titanylphosphate laser vaporization of the prostate", Eur Urol, 48, pp.608~613 (2005)
  11. Sarica K, "Photoselective vaporization of the enlarged prostate with KTP laser: long-term results in 240 patients", J Endourol, 19, pp.1199~1202 (2005)
  12. Barber NJ, "Use of expired breath ethanol measurements in evaluation of irrigant absorption during high-power potassium titanyl phosphate laser vaporization of prostate", Urology, 67, pp.80~83 (2006)
  13. Monoski MA, "Urodynamic predictors of outcomes with photoselective laser vaporization prostatectomy in patients with benign prostatic hyperplasia and preoperative retention", Urology, 68, pp.312~317 (2006)
  14. Te AE, "Impact of prostate-specific antigen level and prostate volume as predictors of efficacy in photoselective vaporization prostatectomy:analysis and results of an ongoing prospective multicentre study at 3 years", BJU Int, 97, pp.1229~1233 (2006)
  15. Bouchier-Hayes DM, "KTP laser versus transurethral resection: early results of a randomized trial", J Endourol, 20, pp.580~585 (2006)
  16. Fu WJ, "Evaluation of greenlight photoselective vaporization of the prostate for the treatment of high-risk patients with benign prostatic hyperplasia", Asian J Androl, 8, pp.367~371 (2006)
  17. Kuntzman RS, "Potassiumtitanyl-phosphate laser vaporization of the prostate: a comparative functional and pathologic study in canines", Urology, 48, pp.575~583 (1996)
  18. Kuntzman RS, "Highpower (60-watt) potassium-titanyl-phosphate laser vaporization prostatectomy in living canines and in human and canine cadavers", Urology, 49, pp.703~708 (1997)
  19. Lee R, "Photoselective vaporization of the prostate using a laser high performance system in the canine model", J Urol, 180, pp.1551~1553 (2008)
  20. Spaliviero M, "Short-term outcomes of Greenlight HPS laser photoselective vaporization prostatectomy (PVP) for benign prostatic hyperplasia (BPH)", J Endourol, 22, pp.2341~2347 (2008)
  21. Rieken M, "Complications of laser prostatectomy: a review of recent data", World J Urol, 28, pp.53~62 (2010)
  22. Krambeck AE, "Holmium laser enucleation of the prostate for prostates larger than 175 grams", J Endourol, 24, pp.433~437 (2010)
  23. Du C, "Holmium laser enucleation of the prostate: the safety, efficacy, and learning experience in China", J Endourol, 22, pp.1031~1036 (2008)
  24. Shingleton WB, "A randomized prospective study of laser ablation of the prostate versus transurethral resection of the prostate in men with benign prostatic hyperplasia", Urology, 54, pp.1017~1021 (1999)
  25. Shingleton WB, "A randomized prospective study of transurethral electrovaporization vs. laser ablation of the prostate in men with benign prostatic hypertrophy", Scand J Urol Nephrol, 32, pp.266~269 (1998)
  26. Bachmann A, "Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): a prospective bi-centre study of perioperative morbidity and early functional outcome", Eur Urol, 48, pp.965~971 (2005)
  27. Reich O, "Experimental comparison of high power (80 W) potassium titanyl phosphate laser vaporization and transurethral resection of the prostate", J Urol, 171, pp.2502~2504 (2004)
  28. Paick JS, "Influence of high-power potassium-titanyl-phosphate photoselective vaporization of the prostate on erectile function: a short-term follow-up study", J Sex Med, 4, pp.1701~1707 (2007)
  29. Naspro R, "A review of the recent evidence (2006-2008) for 532-nm photoselective laser vaporization and holmium laser enucleation of the prostate", Eur Urol, 55, pp.1345~1357 (2009)

관련 논문AI추천

Comparison of Efficacy of Different Surgical Techniques for Benign Prostatic Obstruction유지웅, 이규성, 이성원, 전성수, 정병창대한배뇨장애요실금학회 · International Neurourology Journal2021 · 제25권 제3호전립선비대증 환자에서 KTP laser를 이용한 전립선절제술의 치료효과 및 안정성에 대한 단기결과김영주, 허정식대한배뇨장애요실금학회 · International Neurourology Journal2008 · 제12권 제1호Factors Affecting the Improvement of the Initial Peak Urinary Flow Rate after Transurethral Resection of the Prostate or Photoselective Vaporization of the Prostate for Treating Benign Prostatic Hyperplasia김동석, 김동준, 전경필, 정태융, 최화섭대한배뇨장애요실금학회 · International Neurourology Journal2011 · 제15권 제1호Holmium Laser Enucleation of Prostate for Benign Prostatic Hyperplasia: Seoul National University Hospital Experience박지현, 배정범, 백재승, 오승준, 오진규, 주민수대한배뇨장애요실금학회 · International Neurourology Journal2011 · 제15권 제1호Preoperative Factors Affecting Postoperative Early Quality of Life During the Learning Curve of Holmium Laser Enucleation of the Prostate고준성, 김상훈, 김준철, 김현우, 김효신, 조강준, 조수연, 한승범대한배뇨장애요실금학회 · International Neurourology Journal2013 · 제17권 제2호Holmium Laser Enucleation of the Prostate is Safe for Patients Above 80 Years: A Prospective Study김명, 오승준, 전호준, 추민수, Songzhe Piao대한배뇨장애요실금학회 · International Neurourology Journal2016 · 제20권 제2호

이 간행물의 다른 논문 (18건)